HemOnc Supplemental Lectures

We are pleased to provide this extensive update of the latest diagnostic and therapeutic advances in the field of oncology.  

Target Audience

This course is designed for hematology and oncology clinicians; internal medicine physicians; oncology nurses; physician assistants; and other health care professionals. 

Course summary
Course opens: 
08/13/2020
Course expires: 
12/31/2021

COVID 19 and Cancer Therapy
Henry Masur, MD

Updates in Breast Cancer
Carey K. Anders, MD

Updates in Lung Cancer
Benjamin P. Levy, MD

Updates in Colon Cancer
John Marshall, MD

Updates in Urologic Cancer
Jeanny Aragon-Ching, MD

New Advances in Pharmacology
Edward Chu, MD

Updates in Pancreatic Cancer
Lynt Johnson, MD

Updates in Thoracic Cancer
Keith Mortman, MD

Telemedicine
Susan Dentzer

Henry Masur, MD
Bethesda, MD


Carey K. Anders, MD
Medical Oncologist
Duke Cancer Center
Medical Director, Brain and Spine Mestastases Program
Durham, NC


Benjamin P. Levy, MD
Associate Professor of Oncology
Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital
Clinical Director of Medical Oncology

John Marshall, MD

Jeanny Aragon-Ching, MD
Associate Professor, Medicine
Virginia Commonwealth University
Clinical Program Director, Genitourinary Cancers 
Inova Dwight and Martha Schar Cancer Institute
Falls Church, VA

Edward Chu, MD
Professor, Medicine, Pharmacology, Chemical Biology
Chief, Hematology-Oncology
University of Pittsburgh School of Medicine
Deputy Director
University of Pittsburgh Cancer Institute
Pittsburgh, PA

Lynt Johnson, MD
Professor of Surgery
Executive Director, Liver and Pancreas Institute for Quality
GW Cancer Center
Washington, DC
 
Keith Mortman, MD
Associate Professor of Surgery
The George Washington University School of Medicine
Director of Thoracic Surgery
Washington, DC

Susan Dentzer
Senior Policy Fellow
Duke-Margolis Center for Health Policy
Washington, DC
Please login or register to take this course.